DZ Bank’s Mesa Laboratories MLAB Stock Holding History

DZ Bank’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-400	Closed	-$56.3K	–	1073
2022 Q3	$56.3K	Buy	400 +200	+100%	+$36.5K	﹤0.01%	940
2022 Q2	$40.8K	Buy	+200	New	+$43.8K	﹤0.01%	971

Other funds holding MLAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

DZ Bank's MLAB Position: Q4 2022 in Review

DZ Bank sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 400 shares — an estimated $56.3K sold.

DZ Bank first reported a position in MLAB in Q2 2022 and held it in 2 quarters. The position peaked at $56.3K in Q3 2022. 159 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

DZ Bank reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
DZ Bank sold 400 Mesa Laboratories shares in Q4 2022, an estimated $56.3K.
DZ Bank first reported a position in Mesa Laboratories in Q2 2022 and held it in 2 quarters.
DZ Bank's Mesa Laboratories position peaked at $56.3K in Q3 2022.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on DZ Bank's 13F filing for Q4 2022, filed 14 Feb 2023.